Search
Filter by Topic
- (-) Remove Reproduction filter Reproduction
- (-) Remove Technologies filter Technologies
- People (3) Apply People filter
- Ethics (2) Apply Ethics filter
- Disorders (1) Apply Disorders filter
- Experiments (1) Apply Experiments filter
- Legal (1) Apply Legal filter
- Organizations (1) Apply Organizations filter
- Places (1) Apply Places filter
- Processes (1) Apply Processes filter
- Publications (1) Apply Publications filter
Filter by Format
- (-) Remove Articles filter Articles
Pages
Preimplantation Genetic Diagnosis
Preimplantation genetic diagnosis (PGD) involves testing for specific genetic conditions prior to the implantation of an embryo in the uterine wall. This form of genetic screening has been made possible by the growth of in-vitro fertilization (IVF) technology, which allows for the early stages of development to occur in a laboratory dish rather than in vivo. The purpose of PGD is to identify what are considered to be abnormal embryos in order to select the most desirable embryos for implantation.
Format: Articles
Subject: Technologies, Reproduction
Zygote Intrafallopian Transfer
Zygote intrafallopian transfer (ZIFT) is an assisted reproductive technology (ART) first used in 1986 to help those who are infertile conceive a child. ZIFT is a hybrid technique derived from a combination of in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) procedures. Despite a relatively high success rate close to that of IVF, it is not as common as its parent procedures due to its costs and more invasive techniques.
Format: Articles
Subject: Technologies, Reproduction
Progestin: Synthetic Progesterone
Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955.
Format: Articles
Subject: Technologies, Reproduction
Gamete Intra-Fallopian Transfer (GIFT)
Various techniques constitute assisted reproduction, one of which is gamete intra-fallopian transfer (GIFT). The first example of GIFT involved primates during the 1970s; however, the technology was unsuccessful until 1984 when an effective GIFT method was invented by Ricardo Asch at the University of Texas Health Sciences Center and the procedure resulted in the first human pregnancy. The GIFT technique was created in hopes of generating an artificial insemination process that mimicked the physiological sequences of normal conception.
Format: Articles
Subject: Technologies, Reproduction
2D Obstetric Ultrasound
The development of the obstetric ultrasound has allowed physicians and embryologists to obtain a clear picture of the developing human embryo and fetus during pregnancy. Obstetric ultrasonography, often referred to as ultrasound, is a technology that uses sound waves to produce images of structures inside the human body. A handheld probe emits sound waves, which are reflected back by the different structures within the body.
Format: Articles
Subject: Technologies, Reproduction
Assisted Reproductive Technologies
Assisted reproductive technologies (ART) are a collection of different techniques designed to help those who are infertile achieve a successful pregnancy. The most popular technology currently in use is in vitro fertilization (IVF), but others include gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI).
Format: Articles
Subject: Technologies, Reproduction
Amniocentesis
Amniocentesis is a test used for prenatal diagnosis of inherited diseases, Rh incompatibility, neural tube defects, and lung maturity. Normally performed during the second trimester of a pregnancy, this invasive procedure allows the detection of health problems in the fetus as early as fifteen weeks gestation. Although amniocentesis does carry some significant risks, the medical community commonly accepts it as a safe and useful procedure.
Format: Articles
Subject: Technologies, Reproduction
Diethylstilbestrol (DES) in the US
Diethylstilbestrol (DES) is an artificially created hormone first synthesized in the late 1930s. Doctors widely prescribed DES first to pregnant women to prevent miscarriages, and later as an emergency contraceptive pill and to treat breast cancer. However, in 1971, physicians showed a link between DES and vaginal cancer during puberty in the children of women who had taken DES while pregnant. Consequently, the US Food and Drug Administration (FDA) banned its use during pregnancy.
Format: Articles
Subject: Reproduction, Technologies
The Shettles Method of Sex Selection
In the 1960s in the United States Landrum B. Shettles developed the Shettles method, which is a procedure for couples to use prior to and during an intercourse to increase their chances of conceiving a fetus of their desired sex. Shettles, a physician, who specialized in obstetrics and gynecology, found a difference in the size and shape of male sperm cells that he correlated with the different sex chromosomes they carry.
Format: Articles
Subject: Technologies, Reproduction
Breast Augmentation Techniques
Breast augmentation involves the use of implants or fat tissue to increase patient breast size. As of 2019, breast augmentation is the most popular surgical cosmetic procedure in the United States, with annual patient numbers increasing by 41 percent since the year 2000. Since the first documented breast augmentation by surgeon Vincenz Czerny in 1895, and later the invention of the silicone breast implant in 1963, surgeons have developed the procedure into its own specialized field of surgery, creating various operating techniques for different results.
Format: Articles
Subject: Technologies, Processes, Reproduction, Ethics
Medical Vibrators for Treatment of Female Hysteria
During the late 1800s through the early 1900s, physicians administered pelvic massages involving clitoral stimulation by early electronic vibrators as treatments for what was called female hysteria. Until the early 1900s, physicians used female hysteria as a diagnosis for women who reported a wide range of complaints and symptoms unexplainable by any other diagnosis at the time. According to historian Rachel Maines, physicians provided pelvic massages for thousands of years to female patients without it being considered erotic or sexually stimulating.
Format: Articles
Subject: Reproduction, Technologies, Ethics
Recombinant Gonadotropins Used in Fertility Treatments
First manufactured in 1988 by Serono laboratories, recombinant gonadotropins are synthetic hormones that can stimulate egg production in women for use in fertility treatments. Recombinant gonadotropins are artificially created using recombinant DNA technology, a technology that joins together DNA from different organisms. In vertebrates, naturally-occurring gonadotropins regulate the growth and function of the gonads, known as testes in males and ovaries in females.
Format: Articles
Subject: Technologies, Reproduction
Transvaginal Ultrasound-Guided Oocyte Retrieval
Transvaginal ultrasound-guided oocyte retrieval, also known as egg retrieval, is a surgical technique used by medical professionals to extract mature eggs directly from the women’s ovaries under the guidance of ultrasound imaging. In 1982, physicians Suzan Lenz and Jorgen Lauritsen at the University of Copenhagen in Copenhagen, Denmark, proposed the technology to improve the egg collection aspect of in vitro fertilization, or IVF. During IVF, a healthcare practitioner must remove mature eggs from a woman’s ovaries to fertilize them with sperm outside of the body.
Format: Articles
Subject: Technologies, Reproduction
Edwin Carlyle (Carl) Wood (1929–2011)
Edwin Carlyle Wood, also known as Carl Wood, was a physician who helped develop in vitro fertilization, or IVF, treatments. From 1964 to 1992, Wood worked as a professor of obstetrics and gynecology at Monash University in Melbourne, Australia, where he was one of the first in the world to lead a team of physicians to establish IVF as a proven treatment for infertility. IVF refers to a medical procedure in which scientists inseminate an egg cell with a sperm cell outside of the body, such as in a glass dish in a clinical setting.
Format: Articles
Subject: People, Technologies, Reproduction
“Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring” (2013), by Jürgen Dinger, Sabine Möhner, and Klaas Heinemann
In October 2013, Jürgen Dinger, Sabine Möhner, and Klaas Heinemann published the article “Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring,” hereafter “Cardiovascular Risk,” in the journal Obstetrics and Gynecology. The authors enrolled patients in the study who were new users of either a vaginal contraceptive ring known as NuvaRing or a combined oral contraceptive pill. A combined oral contraceptive pill contains a formulation of the hormones progesterone and estrogen.
Format: Articles
Subject: Technologies, Reproduction
NuvaRing
The NuvaRing is a self-administered hormonal contraceptive device in the form of a flexible plastic ring that is inserted into the vagina. It releases the hormones etonogestrel and ethinylestradiol, which are synthetic forms of the female reproductive hormones progesterone and estrogen, respectively. The pharmaceutical company Organon first made NuvaRing in the Netherlands in 1980s. The Netherlands first approved it for use in February of 2001, and the United States did the same in October of that year.
Format: Articles
Subject: Technologies, Reproduction, Legal